$IKT Cashflow Statement | Understand Stock

$IKT

$1.52 -$0.07 (4.4%) Close

$IKT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net Income Loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Stock-based compensation expense
Non-cash consulting and marketing fees
Non-cash interest
Non-cash PPP loan forgiveness
Warrant expense
Write-off of in-process research and development
Non-cash accretion on marketable securities
Changes in operating assets and liabilities:
Accounts receivable
Operating lease right of use assets
Prepaid expenses and other assets
Prepaid research and development
Other assets
Accounts payable
Operating lease liabilities
Accrued expenses and other current liabilities
Deferred revenue

Net cash used in operating activities
Cash flows from investing activities
Purchases of equipment and improvements
Purchases of investments - marketable securities
Maturities of investments - marketable securities
Acquired in-process research and development
Net cash provided by (used in) investing activities
Cash flows from financing activities
Proceeds from notes payable
Deferred offering costs
Repayments of note payable
Issuance of common stock from exercise of stock options
Payment of employee taxes in connection with stock option exercise
Proceeds from issuance of common stock from public offerings, net of issuance costs
Net cash provided by financing activities

Net increase in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Supplemental disclosures of cash flow information
Cash paid for interest
Insurance premium financing
Issuance costs
PPP loans forgiveness
Cash paid for amounts included in the measurement of operating lease liabilities

Non-cash investing and financing activities
Notes payable settled with common stock
Notes payable settled with new notes payable
Contingent consideration
Non-cash IPR&D acquired through common stock contingently issued shares
Non-cash financing costs included in Accounts payable
CorHepta transaction costs
Write-off of fully depreciated equipment and improvements

Comments